跳至主要内容
临床试验/IRCT201202251556N35
IRCT201202251556N35已完成2 期

The effect of intranasal oxytocin on negative symptoms in patients with chronic schizophrenia: a double blind and placebo controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Age between 18-50, Diagnosis of Schizophrenia based on DSM IV 3 chronic Schizophrenia( duration of the disorder>2 years), Minimum Score of 60 on Positive and Negative Scale

排除标准

  • 1- Substance dependence,2- IQ <70, 3-any other mental disorder on axis I, 4-Any serious medical or neurological problem ,5- receiving ECT during the last 14 days, 6- hepatic disease

研究者

相似试验